A nationally representative survey of 100 US-based healthcare providers managing sickle cell disease patients reveals significant underutilization of red blood cell exchange, a procedure that removes damaged red blood cells and replaces them with donor cells. Despite the vast majority of surveyed providers reporting access to the technology, treatment rates remain below 3% among their patient populations.
The research identified multiple obstacles preventing wider adoption of the therapy. Healthcare providers cited difficulties coordinating between medical departments, insufficient supplies of donated blood, and limited familiarity with the procedure as primary barriers. Only 5% of surveyed providers reported encountering no obstacles in delivering the treatment. Among patients themselves, insurance coverage concerns represent a major impediment to accessing red blood cell exchange therapy.
Sickle cell disease, an inherited disorder affecting hemoglobin function, impacts more than 100,000 people in the United States and approximately 8 million worldwide. The condition disproportionately affects people of color, with 90% of diagnosed patients being non-Hispanic Black or African American and an estimated 3%-9% being Hispanic or Latino. Geographic and socioeconomic factors compound treatment challenges, as roughly 80% of sickle cell patients rely on Medicaid and many reside in rural areas with limited access to specialized care facilities.
Experts emphasize the need for expanded comprehensive sickle cell disease centers capable of providing coordinated services including hematology, transfusion medicine, and specialized nursing support. Current gaps in provider knowledge and awareness regarding available therapies further restrict patient access. Establishing networks of informed healthcare providers and increasing the number of institutions equipped with apheresis technology could help address these disparities and make the treatment more accessible to patients across different geographic regions.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI